These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. ADAR regulates APOL1 via A-to-I RNA editing by inhibition of MDA5 activation in a paradoxical biological circuit. Riella CV; McNulty M; Ribas GT; Tattersfield CF; Perez-Gill C; Eichinger F; Kelly J; Chun J; Subramanian B; Guizelini D; ; Alper SL; Pollak MR; Sampson MG; Friedman DJ Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2210150119. PubMed ID: 36282916 [No Abstract] [Full Text] [Related]
4. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation. de Reuver R; Dierick E; Wiernicki B; Staes K; Seys L; De Meester E; Muyldermans T; Botzki A; Lambrecht BN; Van Nieuwerburgh F; Vandenabeele P; Maelfait J Cell Rep; 2021 Aug; 36(6):109500. PubMed ID: 34380029 [TBL] [Abstract][Full Text] [Related]
5. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown. Chung H; Calis JJA; Wu X; Sun T; Yu Y; Sarbanes SL; Dao Thi VL; Shilvock AR; Hoffmann HH; Rosenberg BR; Rice CM Cell; 2018 Feb; 172(4):811-824.e14. PubMed ID: 29395325 [TBL] [Abstract][Full Text] [Related]
6. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways. Nakahama T; Kawahara Y Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491 [TBL] [Abstract][Full Text] [Related]
7. What do editors do? Understanding the physiological functions of A-to-I RNA editing by adenosine deaminase acting on RNAs. Heraud-Farlow JE; Walkley CR Open Biol; 2020 Jul; 10(7):200085. PubMed ID: 32603639 [TBL] [Abstract][Full Text] [Related]
8. RNA editing and immune control: from mechanism to therapy. Hu SB; Li JB Curr Opin Genet Dev; 2024 Jun; 86():102195. PubMed ID: 38643591 [TBL] [Abstract][Full Text] [Related]
9. Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasis. Heraud-Farlow JE; Chalk AM; Linder SE; Li Q; Taylor S; White JM; Pang L; Liddicoat BJ; Gupte A; Li JB; Walkley CR Genome Biol; 2017 Sep; 18(1):166. PubMed ID: 28874170 [TBL] [Abstract][Full Text] [Related]
10. Adenosine-to-inosine RNA editing in the immune system: friend or foe? Nakahama T; Kawahara Y Cell Mol Life Sci; 2020 Aug; 77(15):2931-2948. PubMed ID: 31996954 [TBL] [Abstract][Full Text] [Related]
11. Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease. Vlachogiannis NI; Sachse M; Georgiopoulos G; Zormpas E; Bampatsias D; Delialis D; Bonini F; Galyfos G; Sigala F; Stamatelopoulos K; Gatsiou A; Stellos K J Mol Cell Cardiol; 2021 Nov; 160():111-120. PubMed ID: 34302813 [TBL] [Abstract][Full Text] [Related]
12. Genetic mapping uncovers cis-regulatory landscape of RNA editing. Ramaswami G; Deng P; Zhang R; Anna Carbone M; Mackay TFC; Billy Li J Nat Commun; 2015 Sep; 6():8194. PubMed ID: 26373807 [TBL] [Abstract][Full Text] [Related]
13. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Liddicoat BJ; Piskol R; Chalk AM; Ramaswami G; Higuchi M; Hartner JC; Li JB; Seeburg PH; Walkley CR Science; 2015 Sep; 349(6252):1115-20. PubMed ID: 26275108 [TBL] [Abstract][Full Text] [Related]
14. Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous. Keegan LP; Hajji K; O'Connell MA Acc Chem Res; 2023 Nov; 56(22):3165-3174. PubMed ID: 37906879 [TBL] [Abstract][Full Text] [Related]
15. Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease. Crooke PS; Tossberg JT; Porter KP; Aune TM J Immunol; 2021 Apr; 206(8):1691-1696. PubMed ID: 33782089 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency. Mehdipour P; Marhon SA; Ettayebi I; Chakravarthy A; Hosseini A; Wang Y; de Castro FA; Loo Yau H; Ishak C; Abelson S; O'Brien CA; De Carvalho DD Nature; 2020 Dec; 588(7836):169-173. PubMed ID: 33087935 [TBL] [Abstract][Full Text] [Related]
18. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy. Nakahama T; Kato Y; Shibuya T; Inoue M; Kim JI; Vongpipatana T; Todo H; Xing Y; Kawahara Y Immunity; 2021 Sep; 54(9):1976-1988.e7. PubMed ID: 34525338 [TBL] [Abstract][Full Text] [Related]
19. Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections. Pfaller CK; George CX; Samuel CE Annu Rev Virol; 2021 Sep; 8(1):239-264. PubMed ID: 33882257 [TBL] [Abstract][Full Text] [Related]
20. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic. Ganem NS; Ben-Asher N; Lamm AT Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]